Rachel Humphrey
Director at Pyxis Oncology, Inc. (PYXS)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $16K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 25SEC | PYXSPyxis Oncology, Inc. | Sell Plan | 1,40095,405 held (−1%) | $0.97 | $1K | +73.2% |
| Mar 25SEC | PYXSPyxis Oncology, Inc. | Sell Plan | 20095,205 held (−0%) | $0.97 | $194 | +73.2% |
| Mar 25SEC | PYXSPyxis Oncology, Inc. | Sell Plan | 13,89681,309 held (−15%) | $1.03 | $14K | +63.1% |
- Sell
Director Rachel Humphrey sold $1K of PYXS at $0.97 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Rachel Humphrey sold $194 of PYXS at $0.97 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Rachel Humphrey sold $14K of PYXS at $1.03 — pre-scheduled 10b5-1 plan sale.